【4521】科研製薬
製薬。関節機能改善剤。
類似企業:
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
保有者 | 2014.3 | 2014.9 | 2015.3 | 2015.9 | 2016.3 | 2016.9 | 2017.3 | 2017.9 | 2018.3 | 2018.9 | 2019.3 | 2019.9 | 2020.3 | 2020.9 | 2021.3 | 2021.9 | 2022.3 | 2022.9 | 2023.3 | 2023.9 | 2024.3 | 2024.9 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日本マスタートラスト信託銀行株式会社(信託口) | 5,121,000 (5.03%) |
4,564,000
![]() |
4,787,000
![]() |
3,340,000
![]() |
1,185,000
![]() |
1,174,000
![]() |
1,749,000
![]() |
2,162,000
![]() |
2,433,000
![]() |
2,361,000
![]() |
2,594,000
![]() |
2,336,000
![]() |
2,586,000
![]() |
2,941,000
![]() |
2,927,000
![]() |
4,581,000
![]() |
4,622,000
![]() |
4,597,000
![]() |
4,702,000
![]() |
4,605,000
![]() |
4,512,000
![]() |
4,886,000
![]() |
野村 絢 | 878,000 (2.32%) |
2,212,000
![]() |
||||||||||||||||||||
東レ株式会社 | 4,589,000 (4.51%) |
4,589,000
![]() |
4,589,000
![]() |
4,589,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,294,000
![]() |
2,040,000
![]() |
農林中央金庫 | 3,686,000 (3.62%) |
3,686,000
![]() |
3,686,000
![]() |
3,686,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
1,843,000
![]() |
株式会社日本カストディ銀行 (信託口) | 2,998,000 (2.94%) |
3,094,000
![]() |
3,482,000
![]() |
4,130,000
![]() |
1,375,000
![]() |
1,397,000
![]() |
1,614,000
![]() |
1,600,000
![]() |
1,552,000
![]() |
1,618,000
![]() |
1,692,000
![]() |
1,535,000
![]() |
1,615,000
![]() |
1,660,000
![]() |
1,552,000
![]() |
1,562,000
![]() |
1,485,000
![]() |
1,601,000
![]() |
1,672,000
![]() |
1,377,000
![]() |
1,233,000
![]() |
1,677,000
![]() |
株式会社みずほ銀行 | 3,686,000 (3.62%) |
3,686,000
![]() |
3,686,000
![]() |
3,686,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
1,474,000
![]() |
STATE STREET BANK AND TRUST COMPANY 505103(常任代理人 株式会社みずほ銀行) | 653,000 (1.72%) |
696,000
![]() |
947,000
![]() |
|||||||||||||||||||
NORTHERN TRUST CO. (AVFC) RE USLNON-TREATY CLIENTS ACCOUNT(常任代理人 香港上海銀行東京支店カストディ業務部) | 727,000 (1.94%) |
655,000
![]() |
697,000
![]() |
936,000
![]() |
||||||||||||||||||
杏林製薬株式会社 | 1,294,000 (1.27%) |
1,294,000
![]() |
1,294,000
![]() |
1,294,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
852,000
![]() |
株式会社南青山不動産 | 658,000 (1.73%) | |||||||||||||||||||||
NORTHERN TRUST CO. (AVFC) RE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE EQUITY TRUST (常任代理人 香港上海銀行東京支店) | 876,000 (2.28%) |
1,382,000
![]() |
1,627,000
![]() |
1,712,000
![]() |
1,909,000
![]() |
1,402,000
![]() |
999,000
![]() |
|||||||||||||||
NORTHERN TRUST CO.(AVFC) RE U.S. TAX EXEMPTED PENSION FUNDS(常任代理人 香港上海銀行東京支店) | 800,000 (2.11%) |
869,000
![]() |
889,000
![]() |
867,000
![]() |
642,000
![]() |
|||||||||||||||||
NORTHERN TRUST CO. (AVFC) RE NON TREATY CLIENTS ACCOUNT(常任代理人 香港上海銀行東京支店 カストディ業務部) | 658,000 (1.76%) | |||||||||||||||||||||
NORTHERN TRUST CO.(AVFC) A/C NON TREATY(常任代理人 香港上海銀行東京支店) | 742,000 (1.98%) | |||||||||||||||||||||
科研製薬従業員持株会 | 1,743,000 (1.71%) |
1,651,000
![]() |
1,560,000
![]() |
1,355,000
![]() |
635,000
![]() |
620,000
![]() |
588,000
![]() |
587,000
![]() |
592,000
![]() |
607,000
![]() |
608,000
![]() |
606,000
![]() |
604,000
![]() |
|||||||||
日本生命保険相互会社 | 1,530,000 (1.5%) |
1,431,000
![]() |
1,360,000
![]() |
1,360,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
680,000
![]() |
612,000
![]() |
612,000
![]() |
|||||
株式会社日本カストディ銀行(信託口7) | 672,000 (1.73%) |
618,000
![]() |
630,000
![]() |
|||||||||||||||||||
株式会社日本カストディ銀行(信託口9) | 824,000 (2.14%) | |||||||||||||||||||||
株式会社日本カストディ銀行(信託口5) | 718,000 (1.48%) |
682,000
![]() |
689,000
![]() |
703,000
![]() |
707,000
![]() |
685,000
![]() |
696,000
![]() |
713,000
![]() |
||||||||||||||
GOVERNMENT OF NORWAY(常任代理人 シティバンク、エヌ・エイ東京支店) | 841,000 (1.74%) |
631,000
![]() |
678,000
![]() |
|||||||||||||||||||
BNP PARIBAS SECURITIES SERVICES LUXEMBOURG/JASDEC SECURITIES/UCITS ASSETS (常任代理人 香港上海銀行) | 651,000 (1.34%) |
819,000
![]() |
996,000
![]() |
1,003,000
![]() |
962,000
![]() |
953,000
![]() |
983,000
![]() |
|||||||||||||||
THE CHASE MANHATTAN BANK 385036 (常任代理人 株式会社みずほ銀行) | 693,000 (1.43%) |
694,000
![]() |
||||||||||||||||||||
共栄火災海上保険株式会社 | 1,248,000 (1.29%) |
1,248,000
![]() |
624,000
![]() |
|||||||||||||||||||
MSCO CUSTOMER SECURITIES(常任代理人 モルガン・スタンレーMUFG証券株式会社) | 561,000 (1.16%) | |||||||||||||||||||||
JP MORGAN CHASE BANK 380634 (常任代理人 株式会社みずほ銀行) | 2,142,000 (2.21%) |
1,540,000
![]() |
||||||||||||||||||||
SSBT OD05 OMNIBUS ACCOUNT-TREATY CLIENTS(常任代理人 香港上海銀行東京支店) | 1,488,000 (1.46%) |
2,147,000
![]() |
||||||||||||||||||||
THE CHASE MANHATTAN BANK,N.A.LONDON SECS LENDING OMNIBUS ACCOUNT(常任代理人 株式会社みずほ銀行) | 1,717,000 (1.69%) |
1,340,000
![]() |